Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between ...

Government investment will accelerate clinical development and strengthen Aspect’s advanced biomanufacturing capabilities for its bioengineered cellular medicinesVANCOUVER, British Columbia--(BUSINESS ...

Regulatory News:Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage ...

SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition ...

Regulatory News:Celyad Oncology (Euronext: CYAD) (the “Company”), today announces its financial results for the fiscal year ...

Further Diversifies Revenue Mix With Leading Position in Industrial, Pharmaceutical End MarketsExpands Mechanical Services ...

Biogen will acquire Apellis for 5.6 billion dollars, adding two approved therapies and boosting growth in immunology and ...

Gedeon Richter's Side-by-Side Conference on Advancing Women's Health brought together Healthcare practitioners from 40 ...

Care Market OverviewThe global digital musculoskeletal (MSK) care market is poised for robust expansion, with an anticipated ...

CNX Therapeutics Limited ("CNX Therapeutics"), a specialty pharmaceutical company focused on improving patient access to essential medicines, today announced it has acquired the rights to Tacrolimus 5 ...

Beverly Hills spine surgeon and principal investigator will present pooled clinical outcomes following recent FDA approval of motion-preserving cervical disc technology BEVERLY HILLS, CA / ACCESS ...

New PDUFA Target Action Date of July 6, 2026 allows FDA additional time to complete its reviewMENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company committed to ...